Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
December 31, 1997
Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen
M Moussa, D Kloth, G Peers, et al.
Journal of Cellular Biochemistry
|
May 1, 1997
Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I). Immuno-dominant and immuno-recessive area
J W Xuan, D Wu, Y Guo, et al.
Annals of the Academy of Medicine, Singapore
|
March 4, 2011
Evaluating the effects of an integrated medical ethics curriculum on first-year students
Jacqueline J L Chin, Teck Chuan Voo, Syahirah Abdul Karim, et al.
Journal of Cellular Biochemistry
|
December 2, 1999
Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients
D Wu, Y Guo, A F Chambers, et al.
The Canadian Journal of Urology
|
June 1, 1996
Prognostic value of angiogenesis and vascular invasion in muscle-invasive bladder cancer
T. Y. Song, H. Razvi, C. A. McLean, et al.
Journal of Cellular Biochemistry
|
May 1, 1997
Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (II). Epitope mapping by monoclonal antibodies
J W Xuan, D Wu, Y Guo, et al.
The Journal of Urology
|
October 12, 2000
PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer
Y Imasato, J W Xuan, H Sakai, et al.
Cancer
|
November 15, 1993
Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation
J L Chin, D Banerjee, S A Kadhim, et al.
Oncogene
|
September 21, 1995
Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue
J W Xuan, J L Chin, Y Guo, et al.
Urology
|
February 1, 1987
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma
G P Murphy, J M Greco, J L Chin, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
December 31, 1997
Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen
M Moussa, D Kloth, G Peers, et al.
Journal of Cellular Biochemistry
|
May 1, 1997
Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I). Immuno-dominant and immuno-recessive area
J W Xuan, D Wu, Y Guo, et al.
Annals of the Academy of Medicine, Singapore
|
March 4, 2011
Evaluating the effects of an integrated medical ethics curriculum on first-year students
Jacqueline J L Chin, Teck Chuan Voo, Syahirah Abdul Karim, et al.
Journal of Cellular Biochemistry
|
December 2, 1999
Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients
D Wu, Y Guo, A F Chambers, et al.
The Canadian Journal of Urology
|
June 1, 1996
Prognostic value of angiogenesis and vascular invasion in muscle-invasive bladder cancer
T. Y. Song, H. Razvi, C. A. McLean, et al.
Journal of Cellular Biochemistry
|
May 1, 1997
Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (II). Epitope mapping by monoclonal antibodies
J W Xuan, D Wu, Y Guo, et al.
The Journal of Urology
|
October 12, 2000
PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer
Y Imasato, J W Xuan, H Sakai, et al.
Cancer
|
November 15, 1993
Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation
J L Chin, D Banerjee, S A Kadhim, et al.
Oncogene
|
September 21, 1995
Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue
J W Xuan, J L Chin, Y Guo, et al.
Urology
|
February 1, 1987
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma
G P Murphy, J M Greco, J L Chin, et al.
Page
of 9